SNAPC2: A Protein Targeted for The Treatment of Neurological Disorders

Target Name: SNAPC2

NCBI ID: G6618

SNAPC2

SNAPC2: A Protein Targeted for The Treatment of Neurological Disorders

SNAPC2 (SNAP45) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of theSnapin gene family, which encodes a family of proteins that are involved in the regulation of synaptic plasticity , a critical aspect of brain function.

The SNAPC2 protein is known for its role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. SNAPC2 is involved in the formation of synapses, which are the connections between neurons in the brain. During development , SNAPC2 helps to ensure that the correct number of synapses are formed and that they are properly connected.

In addition to its role in synaptic plasticity, SNAPC2 has also been shown to be involved in the regulation of other important cellular processes in the body. For example, studies have shown that SNAPC2 is involved in the regulation of cell death, and that it helps to protect cells from programmed cell death.

SNAPC2 is also known for its role in the development and progression of various neurological disorders, including Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the development of characteristic symptoms, such as difficulty with memory, movement, and thinking.

The discovery of SNAPC2 as a potential drug target or biomarker has significant implications for the treatment of these disorders. If SNAPC2 is found to be involved in the development and progression of these conditions, then drugs that target SNAPC2 may be effective in treating these disorders.

In addition to its potential therapeutic applications, SNAPC2 has also been shown to be a promising biomarker for the detection of these conditions. By measuring the levels of SNAPC2 in brain tissue, researchers may be able to use SNAPC2 as a diagnostic tool for Alzheimer's disease and Parkinson's disease.

Overall, SNAPC2 is a protein that is involved in a critical aspect of brain function, and its role in the regulation of synaptic plasticity and the development and progression of neurological disorders makes it an attractive target for drug development. Further research is needed to fully understand the role of SNAPC2 in these processes, and to determine the most effective way to use it as a therapeutic or diagnostic tool.

Protein Name: Small Nuclear RNA Activating Complex Polypeptide 2

Functions: Part of the SNAPc complex required for the transcription of both RNA polymerase II and III small-nuclear RNA genes. Binds to the proximal sequence element (PSE), a non-TATA-box basal promoter element common to these 2 types of genes. Recruits TBP and BRF2 to the U6 snRNA TATA box

The "SNAPC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNAPC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets